Futura Medical

FUM · AIM · Health Care · mcap £3.3m · 0.2p

Beta Briefing, track record and signals & risks are not ready for Futura Medical yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 01 Sep 26 ↗

Revenue: £2.3m
Operating profit: −£3.6m
Net income: −£3.7m
Free cash flow: −£6.5m
Net cash: £1.2m
Market cap: £3.3m
EV / EBIT: –
FCF yield: −200.4%
Price / book: 1.6×

Latest half-year · H1 26 vs H1 25 results 01 Sep 26 ↗

Revenue: £1.6m
Operating profit: −£1.2m
Net income: −£1.2m
Cash from operations: −£2.2m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures · multi-year

Income statement Balance sheet Cash flow

Latest interim Latest annual

Unaudited Interim Results 2026, published 01 Sep 26 · read the announcement ↗

Consolidated Statement of Comprehensive Income · For the six months ended 30 June 2026

	Unaudited 6 months ended 30 June 2026 £	Unaudited 6 months ended 30 June 2025 £	Audited year ended 31 December 2025 £
Revenue	1,621,524	1,001,154	1,696,660
Cost of Goods	(116)	(758,036)	(456,707)
Gross profit	1,621,408	243,118	1,239,953
Research and development costs	(729,856)	(761,740)	(1,868,014)
Administrative expenses - Pre-exceptional costs	(2,187,922)	(2,642,533)	(4,682,827)
Administration expenses- Exceptional costs	-	(4,053,000)	(4,053,000)
Total administrative expenses	(2,187,922)	(6,695,533)	(8,735,827)
Other Operating Income	100,000	-	255,000
Operating (loss)/profit	(1,196,369)	(6,724,155)	(9,108,888)
Finance income	15,219	38,190	38,190
(Loss)/profit before tax	(1,181,151)	(6,685,965)	(9,070,698)
Taxation	-	100,000	-
Total comprehensive (loss)/profit for the period attributable to owners of the parent company	(1,181,151)	(6,585,965)	(9,070,698)
Basic (loss)/profit per share (pence)	(0.20)	(2.17)	(2.78)
Diluted (loss)/profit per share (pence)	(0.20)	(2.17)	(2.78)

Consolidated Statement of Financial Position · As at 30 June 2026

	Unaudited 30 June 2026 £	Unaudited 30 June 2025 £	Audited 31 December 2025 £
Assets
Non-current assets
Property, plant and equipment	692,378	807,605	747,528
Total non-current assets	692,378	807,605	747,528
Current assets
Inventories	79	33,710	260
Trade and other receivables	1,859,930	856,959	814,608
Current tax asset	355,000	100,000	255,000
Cash and cash equivalents	1,244,158	3,689,549	3,401,631
Total current assets	3,459,167	4,680,218	4,471,499
Liabilities
Current liabilities
Trade and other payables	(1,392,458)	(1,589,394)	(1,659,939)
Provisions	(509,038)	(509,038)	(509,038)
Total current liabilities	(1,901,496)	(2,098,432)	(2,168,977)
Net current assets	1,557,671	2,581,787	2,302,522
Non-current liabilities Contract liabilities (long-term)	(244,851)	(342,588)	(244,851)
Provisions	-	-	-
Total non-current liabilities	(244,851)	(342,588)	(244,851)
Total liabilities	(2,146,347)	(2,441,020)	(2,413,828)
Total net assets	2,005,198	3,046,803	2,805,199
Capital and reserves attributable to owners of the Parent Company
Share capital	1,162,655	607,659	1,162,655
Share premium	72,845,717	71,269,186	72,845,717
Merger reserve	1,152,165	1,152,165	1,152,165
Warrant reserve	216,563	-	216,563
Retained losses	(73,371,902)	(69,982,207)	(72,571,901)
Total equity	2,005,198	3,046,803	2,805,199

Consolidated Statement of Cash Flows · For the six months ended 30 June 2026

	Unaudited 6 months ended 30 June 2026 £	Unaudited 6 months ended 30 June 2025 £	Audited year ended 31 December 2025 £
Cash flows from operating activities
Loss before tax	(1,181,151)	(6,685,965)	(9,070,697)
Adjustments for
Depreciation	55,918	62,002	121,991
Profit on disposal of fixed assets	-	-	88
Finance income	(15,219)	(38,190)	(38,190)
Foreign exchange differences	-	-
Provisions - Inventory write down	-	490,000	490,000
Impairment losses	-	-	3,220,000
Taxation credit	-	-	(255,000)
Share-based payment charge	381,148	635,760	530,799
Cash flows used in operating activities before changes in working capital	(759,304)	(2,316,393)	(5,001,010)
Decrease in inventories	(180)	(67,804)	(34,355)
(Increase)/decrease in trade and other receivables	(1,145,322)	1,591,506	1,633,857
Decrease in trade and other payables	(267,481)	(2,186,328)	(2,213,520)
Cash used in operations	(2,172,287)	(2,979,019)	(5,615,027)
Income tax received	-	-	-
Net cash used in operating activities	(2,172,287)	(2,979,019)	(5,615,027)
Cash flows from investing activities
Purchase of plant and equipment	-	-	-
Interest received	15,219	38,190	38,190
Cash generated by investing activities	15,219	38,190	38,190
Cash flows from financing activities
Issue of ordinary shares	-	23,230	2,789,174
Expenses paid in connection with share issues	-	-	(406,906)
Cash generated by financing activities	-	23,230	2,382,268
Decrease in cash and cash equivalents	(2,157,068)	(2,906,652)	(3,194,570)
Cash and cash equivalents at beginning of period	3,401,631	6,596,201	6,596,201
Net foreign exchange differences	(405)	-	-
Cash and cash equivalents at end of period	1,244,158	3,689,549	3,401,631

Unaudited Results for the Year Ended 31 Dec 2025, published 29 Apr 26 · read the announcement ↗

UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME · For the year ended 31 December 2025

	Year ended 31 December 2025 £	Year ended 31 December 2024 £
Revenue	1,696,660	13,926,122
Cost of sales	(456,707)	(4,236,788)
Gross profit	1,239,953	9,689,334
Research and development costs	(1,868,014)	(1,742,274)
Administrative expenses - Pre-exceptional costs	(4,682,827)	(6,830,765)
Administrative expenses - Exceptional costs	(4,053,000)	-
Total administrative expenses	(8,735,827)	(6,830,765)
Other operating income	255,000	127,611
Operating (loss)/profit	(9,108,888)	1,243,906
Finance income	38,190	46,939
(Loss)/profit before tax	(9,070,698)	1,290,845
Taxation	-	2,165
(Loss)/profit for the year being total comprehensive (loss)/profit attributable to owners of the Parent Company	(9,070,698)	1,293,010
Basic (loss)/profit per share (pence)	(2.78)	0.43
Diluted (loss)/profit per share (pence)	(2.78)	0.41

UNAUDITED CONSOLIDATED STATEMENT OF FINANCIAL POSITION · As at 31 December 2025

	As at 31 December 2025 £	As at 31 December 2024 £
Assets
Non-current assets
Property, plant and equipment	747,528	4,089,607
Total non-current assets	747,528	4,089,607
Current assets
Inventories	260	455,906
Trade and other receivables	814,608	2,448,465
Current tax asset	255,000	-
Cash and cash equivalents	3,401,631	6,596,201
Total current assets	4,471,499	9,500,572
Liabilities
Current liabilities
Trade and other payables	(1,659,939)	(3,557,813)
Provisions	(509,038)	(286,948)
Total current liabilities	(2,168,977)	(3,844,761)
Net current assets	2,302,522	5,655,811
Non-current liabilities
Contract liabilities (long-term)	(244,851)	(342,587)
Provisions	-	(440,000)
Total non-current liabilities	(244,851)	(782,587)
Total liabilities	(2,413,828)	(4,627,348)
Net assets	2,805,199	8,962,831
Capital and reserves attributable to owners of the Parent Company
Share capital	1,162,655	607,407
Share premium	72,845,717	71,235,261
Merger reserve	1,152,165	1,152,165
Warrant reserve	216,563	-
Retained losses	(72,571,901)	(64,032,002)
Total equity	2,805,199	8,962,831
UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended 31 December 2025
Notes £ £ £ £ £ £
At 1 January 2024	(67,347,103)	5,476,819
Total comprehensive profit for the year	1,293,010	1,293,010
Share-based payment	2,022,091	2,022,091
Shares issued during the year	-	170,911
Transactions with owners	2,022,091	2,193,002
At 31 December 2024	(64,032,002)	8,962,831
Total comprehensive loss for the year	(9,070,698)	(9,070,698)
Share-based payment	530,799	530,799
Shares issued during the year	-	2,165,704
Warrants issued	-	216,563
Transactions with owners	530,799	2,913,066
At 31 December 2025	(72,571,901)	2,805,199

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS · For the year ended 31 December 2025

	Year ended 31 December 2025 £	Year ended 31 December 2024 £
Cash flows from operating activities
(Loss)/profit before tax	(9,070,697)	1,290,844
Adjustments for
Depreciation	121,991	121,832
Profit on disposal of fixed assets	88	612
Finance income	(38,190)	(46,939)
Foreign exchange differences	-	-
Provisions - Inventory write down	490,000	-
Impairment losses	3,220,000	-
Taxation credit	(255,000)	-
Share-based payment charge	530,799	2,022,091
Cash flows generated by/(used in) operating activities before changes in working capital	(5,001,010)	3,388,440
Increase in inventories	(34,355)	(455,567)
Decrease/(increase) in trade and other receivables	1,633,857	(1,208,290)
Decrease in trade and other payables	(2,213,520)	(1,712,186)
Cash generated by/(used in) operations	(5,615,027)	12,397
Income tax received	-	379,075
Cash generated by/(used in) operating activities	(5,615,027)	391,472
Cash flows from investing activities
Purchase of property, plant and equipment	-	(1,726,965)
Interest received	38,190	46,939
Cash used in investing activities	38,190	(1,680,026)
Cash flows from financing activities
Issue of ordinary shares	2,789,174	170,911
Expenses paid in connection with share issues	(406,906)	-
Cash generated by financing activities	2,382,268	170,911
(Decrease)/increase in cash and cash equivalents	(3,194,570)	(1,117,643)
Cash and cash equivalents at beginning of year	6,596,201	7,714,183
Net foreign exchange differences	-	(339)
Cash and cash equivalents at end of year	3,401,631	6,596,201

As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 01 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue to operating profit
Revenue	2.3	1.7	13.9
Gross profit	2.6	1.2	9.7
Exceptional / adjusting items	0.0	(4.1)	–
Operating profit	(3.6)	(9.1)	1.2
Share-based payments	0.3	0.5	2.0
Operating profit to net income
Profit before tax	(3.6)	(9.1)	1.3
Tax	(0.1)	0.0	0.0
Net income (owners)	(3.7)	(9.1)	1.3
Per share
EPS basic	(0.8p)	(2.8p)	0.4p
EPS diluted	(0.8p)	(2.8p)	0.4p

	H1 26	vs H1 25	H2 25	H1 25
Revenue to operating profit
Revenue	1.6	+62%	0.7	1.0
Gross profit	1.6	n/m	1.0	0.2
Exceptional / adjusting items	0.0	n/m	0.0	(4.1)
Operating profit	(1.2)	n/m	(2.4)	(6.7)
Share-based payments	0.4	−40%	(0.1)	0.6
Operating profit to net income
Profit before tax	(1.2)	n/m	(2.4)	(6.7)
Tax	0.0	n/m	(0.1)	0.1
Net income (owners)	(1.2)	n/m	(2.5)	(6.6)
Per share
EPS basic	(0.2p)	–	(0.6p)	(2.2p)
EPS diluted	(0.2p)	–	(0.6p)	(2.2p)

	LTM Jun 26	FY 25	FY 24
Operating activities
Cash from operations	(4.8)	(5.6)	0.4
Investing activities
Capex (PP&E)	–	–	(1.7)
Financing activities
Shares issued	2.8	2.8	0.2

	H1 26	vs H1 25	H2 25	H1 25
Operating activities
Cash from operations	(2.2)	n/m	(2.6)	(3.0)
Financing activities
Shares issued	0.0	n/m	2.8	0.0

	Latest Jun 26	FY 25	FY 24
Non-current assets
Property, plant & equipment	0.7	0.7	4.1
Current assets
Inventories	0.0	0.0	0.5
Trade receivables	1.9	0.8	2.4
Cash	1.2	3.4	6.6
Current assets	3.5	4.5	9.5
Current liabilities
Trade payables	1.4	1.7	3.6
Current liabilities	1.9	2.2	3.8
Non-current liabilities
Non-current liabilities	0.2	0.2	0.8
Total liabilities	2.1	2.4	4.6
Equity
Total equity	2.0	2.8	9.0

	H1 26	H2 25	H1 25	H2 24
Non-current assets
Property, plant & equipment	0.7	0.7	0.8	4.1
Current assets
Inventories	0.0	0.0	0.0	0.5
Trade receivables	1.9	0.8	0.9	2.4
Cash	1.2	3.4	3.7	6.6
Current assets	3.5	4.5	4.7	9.5
Current liabilities
Trade payables	1.4	1.7	1.6	3.6
Current liabilities	1.9	2.2	2.1	3.8
Non-current liabilities
Non-current liabilities	0.2	0.2	0.3	0.8
Total liabilities	2.1	2.4	2.4	4.6
Equity
Total equity	2.0	2.8	3.0	9.0

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.